3
Disclosures
Jan 22, 2026 — Mar 24, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 24 Other STELLA PHARMA: Seeks Approval for Boron-Based Cancer Drug PDF
Mar 23 Other STELLA PHARMA: Begins BNCT Treatments in China PDF
Mar 17 Other STELLA PHARMA: Submits Application for Recurrent Meningioma Drug Approval PDF

Disclosure Types

Other: 3